Anavex Life Sciences (AVXL) Tops Q2 EPS by 2c

Anavex Life Sciences (NASDAQ: AVXL) reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• Barclays Upgrades 1&1 AG (1U1:GR) to Overweight
• Micron Technology (MU) PT Raised to $1,280 at Baird
• Micron Technology (MU) PT Raised to $1,100 at Goldman Sachs